BX
Botanix Pharmaceuticals Limited
BXPHF · OTC
$0.01 -43.33% (-$0.01)
1M +7.14%
Market Cap $39.3M
P/E Ratio -
Div. Yield -
ROE 95.70%
Bulios Fair Price
$0.02
96.1% upside
Current Price
$0.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BXPHF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.14x
P/B 0.62x
P/E N/A
Growth
100 /100
Growing Rev. growth 109.05%
Book val. growth 40.34%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 172.20%
FCF margin 187.17%
Net margin 202.15%
Quality
4 /100
Poor ROIC 77.62%
Asset turnover 0.33x
ROE 95.70%
Debt
69 /100
Low Debt/Equity 0.23x
Int. coverage -24.43x
Current ratio 2.59x
Stability
26 /100
Unstable Beta 0.86x
Profitable years 0
Rev. volatility 273.32%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BXPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howie McKibbon
Employees
11
Headquarters
Melbourne
Upcoming events
03 MAR
Earnings
Upcoming earnings report